154 related articles for article (PubMed ID: 18602014)
21. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
Willette RN; Ohlstein EH; Mitchell MP; Sauermelch CF; Beck GR; Luttmann MA; Hay DW
J Pharmacol Exp Ther; 1997 Feb; 280(2):695-701. PubMed ID: 9023281
[TBL] [Abstract][Full Text] [Related]
22. Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction.
Ivy D; McMurtry IF; Yanagisawa M; Gariepy CE; Le Cras TD; Gebb SA; Morris KG; Wiseman RC; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2001 May; 280(5):L1040-8. PubMed ID: 11290529
[TBL] [Abstract][Full Text] [Related]
23. Endothelin-1-induced venous contraction is maintained in DOCA-salt hypertension; studies with receptor agonists.
Watts SW; Fink GD; Northcott CA; Galligan JJ
Br J Pharmacol; 2002 Sep; 137(1):69-79. PubMed ID: 12183332
[TBL] [Abstract][Full Text] [Related]
24. [Effects of endothelin receptor antagonist on the hypoxic pulmonary hypertension].
Chen W; Cheng D
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):370-2, 386. PubMed ID: 12545837
[TBL] [Abstract][Full Text] [Related]
25. ETA-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat.
DiCarlo VS; Chen SJ; Meng QC; Durand J; Yano M; Chen YF; Oparil S
Am J Physiol; 1995 Nov; 269(5 Pt 1):L690-7. PubMed ID: 7491990
[TBL] [Abstract][Full Text] [Related]
26. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats.
Chen SJ; Chen YF; Opgenorth TJ; Wessale JL; Meng QC; Durand J; DiCarlo VS; Oparil S
J Cardiovasc Pharmacol; 1997 Jun; 29(6):713-25. PubMed ID: 9234651
[TBL] [Abstract][Full Text] [Related]
27. A novel and selective endothelin ET(A) receptor antagonist YM598 prevents the development of chronic hypoxia-induced pulmonary hypertension in rats.
Yuyama H; Fujimori A; Sanagi M; Koakutsu A; Noguchi Y; Sudoh K; Sasamata M; Miyata K
Vascul Pharmacol; 2005 Jun; 43(1):40-6. PubMed ID: 15975532
[TBL] [Abstract][Full Text] [Related]
28. Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist.
Iglarz M; Binkert C; Morrison K; Fischli W; Gatfield J; Treiber A; Weller T; Bolli MH; Boss C; Buchmann S; Capeleto B; Hess P; Qiu C; Clozel M
J Pharmacol Exp Ther; 2008 Dec; 327(3):736-45. PubMed ID: 18780830
[TBL] [Abstract][Full Text] [Related]
29. Activation of the right ventricular endothelin (ET) system in the monocrotaline model of pulmonary hypertension: response to chronic ETA receptor blockade.
Jasmin JF; Cernacek P; Dupuis J
Clin Sci (Lond); 2003 Dec; 105(6):647-53. PubMed ID: 12823096
[TBL] [Abstract][Full Text] [Related]
30. Endothelin-A receptor blockade in porcine pulmonary hypertension.
Ambalavanan N; Philips JB; Bulger A; Oparil S; Chen YF
Pediatr Res; 2002 Dec; 52(6):913-21. PubMed ID: 12438670
[TBL] [Abstract][Full Text] [Related]
31. Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation.
Homma N; Nagaoka T; Morio Y; Ota H; Gebb SA; Karoor V; McMurtry IF; Oka M
J Cardiovasc Pharmacol; 2007 Dec; 50(6):697-702. PubMed ID: 18091588
[TBL] [Abstract][Full Text] [Related]
32. Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries.
Mickley EJ; Gray GA; Webb DJ
Br J Pharmacol; 1997 Apr; 120(7):1376-82. PubMed ID: 9105715
[TBL] [Abstract][Full Text] [Related]
33. Chronic intrauterine pulmonary hypertension alters endothelin receptor activity in the ovine fetal lung.
Ivy DD; Ziegler JW; Dubus MF; Fox JJ; Kinsella JP; Abman SH
Pediatr Res; 1996 Mar; 39(3):435-42. PubMed ID: 8929863
[TBL] [Abstract][Full Text] [Related]
34. EndothelinB receptor-mediated contraction of human and rat pulmonary resistance arteries and the effect of pulmonary hypertension on endothelin responses in the rat.
McCulloch KM; MacLean MR
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S169-76. PubMed ID: 8587353
[TBL] [Abstract][Full Text] [Related]
35. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus.
Ivy DD; Parker TA; Ziegler JW; Galan HL; Kinsella JP; Tuder RM; Abman SH
J Clin Invest; 1997 Mar; 99(6):1179-86. PubMed ID: 9077525
[TBL] [Abstract][Full Text] [Related]
36. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.
Ivy DD; Kinsella JP; Abman SH
J Clin Invest; 1994 May; 93(5):2141-8. PubMed ID: 8182146
[TBL] [Abstract][Full Text] [Related]
37. Influence of applied tension and nitric oxide on responses to endothelins in rat pulmonary resistance arteries: effect of chronic hypoxia.
MacLean MR; McCulloch KM
Br J Pharmacol; 1998 Mar; 123(5):991-9. PubMed ID: 9535030
[TBL] [Abstract][Full Text] [Related]
38. Endothelin receptor blockade attenuates air embolization-induced pulmonary hypertension in sheep.
Miyahara T; Koizumi T; Kubo K; Hanaoka M; Kaneki T; Yamamoto H; Ge RL; Fujimoto K; Kobayashi T; Shibamoto T
Eur J Pharmacol; 1999 Dec; 385(2-3):163-9. PubMed ID: 10607872
[TBL] [Abstract][Full Text] [Related]
39. The role of atrial natriuretic peptide and endothelin in hypoxia induced pulmonary hypertension.
Chen YF; Li H; Elton TS; Yang RH; Jin H; Oparil S
Chin J Physiol; 1994; 37(3):165-83. PubMed ID: 7705179
[TBL] [Abstract][Full Text] [Related]
40. Role of endothelin-1 receptor antagonists in vasoconstriction mediated by endothelin and other vasoconstrictors in human internal mammary artery.
He GW; Liu MH; Yang Q; Furnary A; Yim AP
Ann Thorac Surg; 2007 Nov; 84(5):1522-7. PubMed ID: 17954056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
